General Anxiety Disorder Market by Therapeutics (Antidepressant, Benzodiazepines and Others): U.S. Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast 2014 – 2020.

U.S. general anxiety disorder market expected to reach USD 3,775 million by end of 2020, growing at a CAGR of 2.4% during 2015 and 2020.

14-Jul-2016 | Number of pages: 70 | Report Code: ZMR-34 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the general anxiety disorder market U.S. region. The study provides historic data of 2014 along with a forecast from 2015 to 2020 based on revenue (USD Million). The study includes drivers and restraints for the general anxiety disorder market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the general anxiety disorder market on a U.S. level.

In order to give the users of this report a comprehensive view on the general anxiety disorder market, we have included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the general anxiety disorder market has also been included. The study encompasses a market attractiveness analysis, wherein therapeutics segments are benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a decisive view on the general anxiety disorder market by segmenting the market based on therapeutics segment. Key therapeutics markets covered under this study includes antidepressant, benzodiazepines and others.

The report segments the U.S. general anxiety disorder market into:

U.S. General anxiety disorder Market: Therapeutics Segment Analysis

  • Antidepressant
  • Benzodiazepines
  • Others (Buspirone)

Related Reports

Tardive Dyskinesia (TD) Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1961 | Report Format:

Global Tardive Dyskinesia (TD) Treatment Market: Overview Tardive dyskinesia (TD) is a neurological disorder that has the involvement of the involuntary movements. The terms can be described as tardive which means delayed and dyskinesia which means abnormal movement. The symptoms of tardive dysk...Read More

Hormone Replacement Therapy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1955 | Report Format:

Global Hormone Replacement Therapy Market: Overview The medical treatment where the patients receive hormones to substitute the naturally occurring hormones with the other hormones or to add naturally occurring hormones that are absent is known as hormone replacement therapy. In the females that...Read More

Communicable Diseases Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1953 | Report Format:

Global Communicable Diseases Treatment Market: Overview The diseases that can spread from one person to another are known as communicable diseases. They are also known as contagious diseases. The harmful pathogens, when transferred from one person to another, cause communicable diseases. These p...Read More

Antigen Skin Test Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1927 | Report Format:

Global Antigen Skin Test Market: Overview In order to gain the information about the cellular immune competence a diagnostic method, antigen skin test is used. The test is mainly performed so that the immune systems can be tested against the antigens. If a person is hypersensitive towards exogen...Read More

Thrombus Precursor Protein Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1918 | Report Format:

Global Thrombus Precursor Protein Market: Overview One of the components of the fibrinolytic and coagulation pathways is the thrombus precursor protein (TpP). The thrombus precursor protein acts as a biomarker that specifies the exposure of the people to serious cardiovascular diseases, especial...Read More

Choose License Type:
Latest Published Reports

View All Published Reports